Microbiome transplant–induced response to immunotherapy

Science https://doi.org/10.1126/science.abb5920 (2020)

A fecal microbiome transplant has shown the potential to induce a response to immunotherapy with antibody to the checkpoint immunoinhibitory receptor PD-1 (anti-PD-1) in people with metastatic melanoma refractory to treatment.

There are known links between the gut microbiome and responses to anti-PD-1 immunotherapy. However, modulating the microbiome as a therapeutic strategy has yet to be tried in the clinic.

Boursi and colleagues carried out a phase 1 trial of ten patients with metastatic melanoma refractory to treatment with anti-PD-1. The affected patients received a fecal microbiome transplant from two donors who had been treated with anti-PD-1 monotherapy and had achieved a compete response. In three of the patients treated, the authors observed a response to the monotherapy, including two complete responses.

Author information



Corresponding author

Correspondence to Hannah Stower.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stower, H. Microbiome transplant–induced response to immunotherapy. Nat Med 27, 21 (2021). https://doi.org/10.1038/s41591-020-01220-6

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing